These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6338155)

  • 21. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
    Kahn RJ; McNair DM; Lipman RS; Covi L; Rickels K; Downing R; Fisher S; Frankenthaler LM
    Arch Gen Psychiatry; 1986 Jan; 43(1):79-85. PubMed ID: 3510602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind study of prochlorperazine, chlordiazepoxide and placebo in psychoneurotic outpatients with dominant symptoms of anxiety.
    Goldberg HL; Finnerty RJ
    Int Pharmacopsychiatry; 1979; 14(5):264-77. PubMed ID: 395128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness.
    Feighner JP; Brauzer B; Gelenberg AJ; Gomez E; Kiev A; Kurland ML; Weiss BL
    Psychopharmacology (Berl); 1979 Mar; 61(2):217-25. PubMed ID: 108739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy in anxiety-depressive syndromes. II. Comparative effects of amitriptyline and limbitrol (chlordiazepoxide-amitriptyline).
    Houck J
    Dis Nerv Syst; 1970 Jun; 31(6):421-6. PubMed ID: 4917419
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential drug effects in neurotic depression.
    Rickels K; Hesbacher P; Downing RW
    Dis Nerv Syst; 1970 Jul; 31(7):468-75. PubMed ID: 4918448
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic indicators of 4-week clinical improvement with chlordiazepoxide and hydroxyzine in anxious neurotic outpatients.
    Rickels K; Csanalosi I; Downing RW; Hesbacher PT
    Int Pharmacopsychiatry; 1971; 6(4):249-53. PubMed ID: 4950567
    [No Abstract]   [Full Text] [Related]  

  • 29. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo response rates in psychotic and nonpsychotic depression.
    Spiker DG; Kupfer DJ
    J Affect Disord; 1988; 14(1):21-3. PubMed ID: 2963048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buspirone in major depression: a controlled study.
    Rickels K; Amsterdam JD; Clary C; Puzzuoli G; Schweizer E
    J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loxapine in neurotic anxiety: some modifiers of treatment response.
    Rickels K; Weise CC; Feldman H; Fee EA; Wiswesser G
    J Int Med Res; 1978; 6(3):180-5. PubMed ID: 348533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of posttraumatic stress disorder with amitriptyline and placebo.
    Davidson J; Kudler H; Smith R; Mahorney SL; Lipper S; Hammett E; Saunders WB; Cavenar JO
    Arch Gen Psychiatry; 1990 Mar; 47(3):259-66. PubMed ID: 2407208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of autonomic crises (attacks of panic)].
    Diukova GM; Shepeleva IP; Vorob'eva OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):3-5. PubMed ID: 1654698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being.
    Kellner R; Rada RT; Andersen T; Pathak D
    Psychopharmacology (Berl); 1979 Aug; 64(2):185-91. PubMed ID: 115039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C; Ceccherininelli A; Rossi A; Maggini C
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
    Georgia EH
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.